Scientific Writer, Integrated Research Management

Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS‑addicted cancers. The company’s R&D pipeline comprises RAS(ON) Inhibitors designed to suppress diverse oncogenic variants of RAS proteins, and RAS Companion Inhibitors for use in combination treatment strategies. As a new member of the Revolution Medicines team, you will join other outstanding Revolutionaries in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.

We are seeking a Scientific Writer with strong nonclinical regulatory experience to support the authoring and integration of nonclinical content for U.S. and global regulatory submissions. This role focuses on developing and integrating nonclinical content beyond INDs and NDAs, including briefing documents, Investigator Brochures, responses to health authority questions, and other submission‑related materials across the U.S., Europe, and Asia.

As a strategic scientific integrator, this individual will translate complex RAS biology and translational pharmacology into clear, compelling regulatory narratives that reflect Rev Med’s deep mechanistic understanding of RAS signaling and frontier targets. The role partners closely with nonclinical subject matter experts (SMEs) in pharmacology, toxicology, and DMPK, as well as Regulatory Affairs, Regulatory Operations, and Medical Writers, to ensure nonclinical strategy and content are scientifically rigorous, aligned, and submission‑ready.

The Scientific Writer will leverage structured source documents, document management systems, and emerging AI‑enabled tools to improve efficiency, consistency, and scalability of nonclinical regulatory writing. This role requires strong organizational skills and the ability to manage multiple programs and cross‑functional inputs simultaneously in a fast‑paced, scientifically rigorous environment.

• Author, integrate, and edit nonclinical sections of regulatory documents across multiple submission types, including INDs, NDAs, briefing documents, amendments, and response to health authority requests.
• Safeguard and articulate the scientific rationale underlying Rev Med’s RAS(ON) and companion inhibitor programs across regulatory communications.
• Develop clear, hypothesis‑driven regulatory narratives that integrate pharmacology, toxicology, and DMPK data, and engage as a critical scientific thought partner to these functions to strengthen mechanistic coherence, regulatory positioning, and alignment with global regulatory expectations (FDA, EMA, and select Asian agencies).
• Collaborate closely with project Medical Writers to ensure nonclinical sections are delivered in alignment with overall timelines and coordinated with related document sections.
• Ensure scientific consistency across programs to preserve and extend Rev Med’s reputation for rigor and mechanistic depth.
• Manage multiple regulatory writing efforts in parallel, balancing priorities across programs and functions in a fast‑paced environment.
• Utilize Regulatory information management systems (e.g., Veeva) and AI‑enabled writing tools to support authoring, review, and lifecycle management of regulatory documents.
• Contribute to templates, guidance, and best practices for global nonclinical regulatory documentation.
• Drive continuous improvement of nonclinical authoring standards, templates, and knowledge management systems.
• Capture and institutionalize lessons learned from prior submissions to improve quality, consistency, and efficiency across programs and regions.

• Advanced degree (PhD preferred; MS considered) in a relevant nonclinical scientific discipline.
• Demonstrated experience authoring or substantially contributing to nonclinical sections of regulatory submissions across multiple document types.
• Strong working knowledge of pharmacology, toxicology, and DMPK and their integration into regulatory narratives.
• Demonstrated ability to synthesize complex mechanistic datasets into coherent, hypothesis‑driven regulatory narratives.
• Comfortable engaging…